A detailed history of Franklin Resources Inc transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 10,564,345 shares of APLT stock, worth $49.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,564,345
Previous 7,017,912 50.53%
Holding current value
$49.3 Million
Previous $23.5 Million 205.56%
% of portfolio
0.02%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$2.25 - $7.4 $7.98 Million - $26.2 Million
3,546,433 Added 50.53%
10,564,345 $71.8 Million
Q4 2023

Feb 09, 2024

SELL
$1.84 - $3.35 $1.71 Million - $3.11 Million
-929,100 Reduced 11.69%
7,017,912 $23.5 Million
Q3 2023

Nov 13, 2023

BUY
$1.26 - $2.77 $352 - $775
280 Added 0.0%
7,947,012 $19.8 Million
Q2 2023

Aug 11, 2023

BUY
$0.77 - $1.8 $2.44 Million - $5.71 Million
3,171,248 Added 66.41%
7,946,732 $10.2 Million
Q2 2022

Aug 11, 2022

BUY
$0.76 - $2.64 $2.42 Million - $8.4 Million
3,179,934 Added 199.3%
4,775,484 $4.53 Million
Q1 2022

May 13, 2022

BUY
$1.48 - $6.22 $695,978 - $2.92 Million
470,256 Added 41.79%
1,595,550 $3.37 Million
Q4 2021

Feb 11, 2022

BUY
$8.77 - $18.29 $2.55 Million - $5.32 Million
291,012 Added 34.88%
1,125,294 $10.1 Million
Q3 2021

Nov 12, 2021

BUY
$13.54 - $22.06 $58,221 - $94,858
4,300 Added 0.52%
834,282 $13.8 Million
Q2 2021

Aug 13, 2021

BUY
$14.05 - $25.04 $1.14 Million - $2.03 Million
81,000 Added 10.81%
829,982 $17.2 Million
Q1 2021

May 13, 2021

BUY
$16.57 - $28.65 $6.36 Million - $11 Million
383,700 Added 105.04%
748,982 $14 Million
Q4 2020

Feb 10, 2021

BUY
$15.44 - $24.23 $216 - $339
14 Added 0.0%
365,282 $8.04 Million
Q2 2020

Aug 13, 2020

BUY
$29.41 - $51.23 $744,278 - $1.3 Million
25,307 Added 7.44%
365,268 $9.37 Million
Q1 2020

May 13, 2020

BUY
$19.54 - $55.47 $6.64 Million - $18.9 Million
339,961 New
339,961 $11.1 Million

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $224M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.